Cargando…
An update on the discovery and development of reversible covalent inhibitors
Small molecule drugs that covalently bind irreversibly to their target proteins have several advantages over conventional reversible inhibitors. They include increased duration of action, less-frequent drug dosing, reduced pharmacokinetic sensitivity, and the potential to target intractable shallow...
Autores principales: | Faridoon, Ng, Raymond, Zhang, Guiping, Li, Jie Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148018/ https://www.ncbi.nlm.nih.gov/pubmed/37305209 http://dx.doi.org/10.1007/s00044-023-03065-3 |
Ejemplares similares
-
An Update on the Status of Potent Inhibitors of Metallo-β-Lactamases
por: Faridoon,, et al.
Publicado: (2013) -
CovalentInDB: a comprehensive database facilitating the discovery of covalent inhibitors
por: Du, Hongyan, et al.
Publicado: (2020) -
Reversible covalent direct thrombin inhibitors
por: Sivaraja, Mohanram, et al.
Publicado: (2018) -
Characterization of Covalent-Reversible EGFR Inhibitors
por: Smith, Steven, et al.
Publicado: (2017) -
Advances in covalent drug discovery
por: Boike, Lydia, et al.
Publicado: (2022)